Companies: 10,795·Total market cap: $144.5T
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

ZBHNYSEHealthcare● Active
$87.22
$-0.11(-0.13%)
Market Cap$16.9B
P/E Ratio
52W High$108.29
52W Low$79.12

Zimmer Biomet Holdings, Inc. (ZBH) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

zbh · stock forecast · 42 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 42 Wall Street analysts in the past 3 months

SellBuy

Hold

42 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
18
Hold
21
Sell
3
Strong Sell
0
Total: 42 · Buy rate: 42.9%

12-Month Price Target

High

$120

Consensus

$96.33

+10.4% upside

Low

$83.00

Median: $93 · Last Close: $87.23

The Zimmer Biomet Holdings, Inc. (ZBH) analyst consensus is Hold, based on ratings from 42 Wall Street analysts over the past 3 months. The average 12-month ZBH price target is $96.33, representing +10.4% upside from the current price of $87.23.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $96 (10.4%)

Consensus Target

$96.33

10.4% upside

High Target

$120

37.6%

Low Target

$83

-4.8%

Current Price

$87.23

as of today

Based on analyst price targets, the ZBH stock price prediction for the next 12 months ranges from $83 to $120. The consensus ZBH price forecast of $96.33 implies 10.4% upside from the current price of $87.23.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$88.411.36%

1-day model range: $88–$88.83. Peak: $88.83 (+1.36%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$83-5.3%
2028$80-8.5%
2029$78-10.6%
2030$77-11.9%
2031-12.7%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%7%43%
7Buy
1Neutral
6Sell
RSI (14)59.8Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ZBH · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$86.00BUY
MA 10$84.50BUY
MA 20$84.22BUY
MA 50$87.42SELL
MA 100$89.64SELL
MA 200$93.23SELL
Current $ZBH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$86.18BUY
EMA 10$85.32BUY
EMA 20$85.06BUY
EMA 50$86.75BUY
EMA 100$88.99SELL
EMA 200$92.10SELL
Current $ZBH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citigroup2026-05-28
Maintains
NeutralNeutral
Wells Fargo2026-04-29
Maintains
Equal WeightEqual Weight
Truist Securities2026-04-29
Maintains
HoldHold
JP Morgan2026-04-29
Maintains
NeutralNeutral
Citigroup2026-04-29
Maintains
NeutralNeutral
Stifel2026-04-29
Maintains
BuyBuy
Barclays2026-04-29
Maintains
UnderweightUnderweight
Citizens2026-04-29
Maintains
Market OutperformMarket Outperform
BTIG2026-03-23
Downgrade ↓
BuyNeutral
Barclays2026-02-12
Maintains
UnderweightUnderweight

Wall Street analysts have recently issued updated ratings on Zimmer Biomet Holdings, Inc. (ZBH) stock. Of the recent 352 rating actions, 34 were upgrades and 34 were downgrades. 42 analysts currently cover ZBH.

Analyst Recommendation Trends

Buy ratings00
Hold ratings211
Sell ratings00

ZBH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$8.6B

↓ 6.9% YoY

Revenue Next Year

$8.9B

↑ 3.6% YoY

EPS This Year

$8.49

EPS Next Year

$9.02

↑ 6.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ZBH EPS of $8.49 for the current fiscal year, based on estimates from 16 analysts. The ZBH revenue forecast is $8.6B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ZBH stock forecast is supported by two independent data sources: analyst consensus ratings from 42 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ZBH price target is $96.33 (+10.4% upside), with an analyst consensus of Hold.

The ZBH short-term stock prediction for tomorrow is $88.41 (+1.36%). The ZBH stock price prediction for 2027 estimates an average of $83. The ZBH stock prediction for 2030 projects a range of $73–$81.

Zimmer Biomet Holdings, Inc. trades on NYSE under the ticker ZBH. The ZBH stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 43% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ZBH forecast · 8 questions

According to 42 Wall Street analysts, the average 12-month ZBH price target is $96.33, with a high forecast of $120.00 and a low of $83.00. The median price target is shown in the chart above when available. This implies +10.4% potential upside from the current price of $87.23.

ZBH price targetWhat is ZBH price targetZBH analyst price targetZBH 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.